|
1
|
Shin HR, Oh JK, Masuyer E, Curado MP,
Bouvard V, Fang YY, Wiangnon S, Sripa B and Hong ST: Epidemiology
of cholangiocarcinoma: An update focusing on risk factors. Cancer
Sci. 101:579–585. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mosadeghi S, Liu B, Bhuket T and Wong RJ:
Sex-specific and race/ethnicity-specific disparities in
cholangiocarcinoma incidence and prevalence in the USA: An updated
analysis of the 2000-2011 Surveillance, Epidemiology and End
Results registry. Hepatol Res. 46:669–677. 2016. View Article : Google Scholar
|
|
3
|
Razumilava N and Gores GJ:
Cholangiocarcinoma. Lancet. 383:2168–2179. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rizvi S, Khan SA, Hallemeier CL, Kelley RK
and Gores GJ: Cholangiocarcinoma - evolving concepts and
therapeutic strategies. Nat Rev Clin Oncol. 15:95–111. 2018.
View Article : Google Scholar
|
|
6
|
Bridgewater J, Galle PR, Khan SA, Llovet
JM, Park JW, Patel T, Pawlik TM and Gores GJ: Guidelines for the
diagnosis and management of intrahepatic cholangiocarcinoma. J
Hepatol. 60:1268–1289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rizvi S and Gores GJ: Emerging molecular
therapeutic targets for cholangiocarcinoma. J Hepatol. 67:632–644.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Balas MM and Johnson AM: Exploring the
mechanisms behind long noncoding RNAs and cancer. Noncoding RNA
Res. 3:108–117. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rafiee A, Riazi-Rad F, Havaskary M and
Nuri F: Long noncoding RNAs: Regulation, function and cancer.
Biotechnol Genet Eng Rev. 34:153–180. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Evans JR, Feng FY and Chinnaiyan AM: The
bright side of dark matter: lncRNAs in cancer. J Clin Invest.
126:2775–2782. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Schmitt AM and Chang HY: Long noncoding
RNAs in cancer pathways. Cancer Cell. 29:452–463. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Prensner JR and Chinnaiyan AM: The
emergence of lncRNAs in cancer biology. Cancer Discov. 1:391–407.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Song H, Xu Y, Shi L, Xu T, Fan R, Cao M,
Xu W and Song J: LncRNA THOR increases the stemness of gastric
cancer cells via enhancing SOX9 mRNA stability. Biomed
Pharmacother. 108:338–346. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, He L, Du Y, Zhu P, Huang G, Luo J,
Yan X, Ye B, Li C, Xia P, et al: The long noncoding RNA lncTCF7
promotes self-renewal of human liver cancer stem cells through
activation of Wnt signaling. Cell Stem Cell. 16:413–425. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zhang Z, Sun L, Zhang Y, Lu G, Li Y and
Wei Z: Long non-coding RNA FEZF1-AS1 promotes breast cancer
stemness and tumorigenesis via targeting miR-30a/Nanog axis. J Cell
Physiol. 233:8630–8638. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Batlle E and Clevers H: Cancer stem cells
revisited. Nat Med. 23:1124–1134. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pützer BM, Solanki M and Herchenröder O:
Advances in cancer stem cell targeting: How to strike the evil at
its root. Adv Drug Deliv Rev. 120:89–107. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Li Y, Cai Q, Li W, Feng F and Yang L: Long
non-coding RNA EPIC1 promotes cholangiocarcinoma cell growth.
Biochem Biophys Res Commun. 504:654–659. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guo L, Zhou Y, Chen Y, Sun H, Wang Y and
Qu Y: LncRNA ASAP1-IT1 positively modulates the development of
cholangiocarcinoma via hedgehog signaling pathway. Biomed
Pharmacother. 103:167–173. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Z, Li J, Ji D, Leng K, Xu Y, Huang L,
Jiang X and Cui Y: Overexpressed long noncoding RNA Sox2ot predicts
poor prognosis for cholangiocarcinoma and promotes cell
proliferation and invasion. Gene. 645:131–136. 2018. View Article : Google Scholar
|
|
21
|
Huang W, Sherman BT and Lempicki RA:
Systematic and integrative analysis of large gene lists using DAVID
bioinformatics resources. Nat Protoc. 4:44–57. 2009. View Article : Google Scholar
|
|
22
|
Huang W, Sherman BT and Lempicki RA:
Bioinformatics enrichment tools: Paths toward the comprehensive
functional analysis of large gene lists. Nucleic Acids Res.
37:1–13. 2009. View Article : Google Scholar :
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
24
|
Kumar S, Williams D, Sur S, Wang JY and Jo
H: Role of flow-sensitive microRNAs and long noncoding RNAs in
vascular dysfunction and atherosclerosis. Vascul Pharmacol.
114:76–92. 2019. View Article : Google Scholar
|
|
25
|
Feng SD, Yang JH, Yao CH, Yang SS, Zhu ZM,
Wu D, Ling HY and Zhang L: Potential regulatory mechanisms of
lncRNA in diabetes and its complications. Biochem Cell Biol.
95:361–367. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Quan J, Pan X, Zhao L, Li Z, Dai K, Yan F,
Liu S, Ma H and Lai Y: LncRNA as a diagnostic and prognostic
biomarker in bladder cancer: A systematic review and meta-analysis.
OncoTargets Ther. 11:6415–6424. 2018. View Article : Google Scholar
|
|
27
|
Wang X, Liu F, Liu X, Wang F, Liao X, Chen
Y, Mao Y, Hua D and Ge X: Long non-coding RNA expression profiles
reveals AK098783 is a biomarker to predict poor prognosis in
patients with colorectal cancer. Jpn J Clin Oncol. 48:480–484.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yao J, Wu L, Meng X, Yang H, Ni S, Wang Q,
Zhou J, Zhang Q, Su K, Shao L, et al: Profiling,
clinicopathological correlation and functional validation of
specific long non-coding RNAs for hepatocellular carcinoma. Mol
Cancer. 16:1642017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma J, Zhang L, Yang P, Zeng ZC and Xiang
ZL: Integrated analysis of long noncoding RNA expression profiles
in lymph node metastasis of hepatocellular carcinoma. Gene.
676:47–55. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang F, Wan M, Xu Y, Li Z, Kang P, Jiang
X, Wang Y, Wang Z, Zhong X, Li C, et al: Transcriptome analysis
reveals dysregulated long non-coding RNAs and mRNAs associated with
extrahepatic cholangiocarcinoma progression. Oncol Lett.
14:6079–6084. 2017.PubMed/NCBI
|
|
31
|
Zhang W, Zhai Y, Wang W, Cao M and Ma C:
Enhanced expression of lncRNA TP73-AS1 predicts unfavorable
prognosis for gastric cancer and promotes cell migration and
invasion by induction of EMT. Gene. 678:377–383. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Li C, Li W, Zhang Y, Zhang X, Liu T, Zhang
Y, Yang Y, Wang L, Pan H, Ji J, et al: Increased expression of
antisense lncRNA SPINT1-AS1 predicts a poor prognosis in colorectal
cancer and is negatively correlated with its sense transcript.
OncoTargets Ther. 11:3969–3978. 2018. View Article : Google Scholar
|
|
33
|
Jin L, He Y, Tang S and Huang S: LncRNA
GHET1 predicts poor prognosis in hepatocellular carcinoma and
promotes cell proliferation by silencing KLF2. J Cell Physiol.
233:4726–4734. 2018. View Article : Google Scholar
|
|
34
|
Carnero A, Garcia-Mayea Y, Mir C, Lorente
J, Rubio IT and LLeonart ME: The cancer stem-cell signaling network
and resistance to therapy. Cancer Treat Rev. 49:25–36. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ravasio R, Ceccacci E and Minucci S:
Self-renewal of tumor cells: Epigenetic determinants of the cancer
stem cell phenotype. Curr Opin Genet Dev. 36:92–99. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Cardinale V, Renzi A, Carpino G, Torrice
A, Bragazzi MC, Giuliante F, DeRose AM, Fraveto A, Onori P,
Napoletano C, et al: Profiles of cancer stem cell subpopulations in
cholangiocarcinomas. Am J Pathol. 185:1724–1739. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Kemmerling R, Alinger B, Dietze O,
Bösmüller HC, Ocker M, Wolkersdörfer GW, Berr F, Neureiter D and
Kiesslich T: Association of stem cell marker expression pattern and
survival in human biliary tract cancer. Int J Oncol. 41:511–522.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yoshikawa S, Zen Y, Fujii T, Sato Y, Ohta
T, Aoyagi Y and Nakanuma Y: Characterization of CD133+
parenchymal cells in the liver: Histology and culture. World J
Gastroenterol. 15:4896–4906. 2009. View Article : Google Scholar : PubMed/NCBI
|
